You just read:

FDA Approves New Liquid Form Of Treatment For Patients With Acute Lymphoblastic Leukemia (ALL) As Part Of A Combination Regimen

News provided by

Rare Disease Therapeutics, Inc.

Apr 30, 2014, 06:35 ET